Gabriella Miller Kids First Research Act 2.0

Discussed how the model of shared responsibility for cybersecurity and resilience, which assigns each critical infrastructure sector a Sector-Risk Management Agency (SRMA) to work closely with on a day-to-day basis (while broadly coordinating with the Department of Homeland Security (DHS)) has and continues to be successful. Expressed support for the Department of Energy (DOE) as the electric sectors SMRA. Discussed how the electric sector has strong mandatory and enforceable cyber and physical security standards, including cyber incident reporting, in place, and why cybersecurity standards and mandates must be risk-based. Discussed how strong industry-government partnerships should be supported to prevent, prepare for, and respond to cybersecurity attacks. Discussed how the federal government should play a greater role in helping electric utilities in assessing vendor cybersecurity practices, such as establishing a federal vendor certification or accreditation program. Discussed how Congress should refrain from imposing additional cyber incident reporting mandates until the Cybersecurity Incident Reporting for Critical Infrastructure Act (CIRCIA) is fully implemented. Provided feedback on H.R. 1160, the Critical Electric Infrastructure Cybersecurity Incident Reporting Act (all provisions). Discussed draft legislation to direct state public utility commissions to establish cybersecurity baselines for distribution utilities (no bill number). Discussed efforts by DOE and other stakeholders on cybersecurity baselines for distribution utilities. Discussed funding opportunities under the Rural and Municipal Utility Advanced Cybersecurity Grant Program. Discussed potential problems with the implementation of the Rural and Municipal Utility Grant Program at DOE (Sec. 40124(d)(1)(A) of the Infrastructure Investment and Jobs Act) regarding the provision of technical assistance. Discussed industry-wide distribution transformer shortage and equipment supply chain challenges. Also discussed the need for more domestic production of electrical equipment. Discussed efforts at DOE to address the distribution transformer supply chain crisis, including President Bidens declaration to use the Defense Production Act. Discussed concerns with the DOEs proposed energy efficiency standards for distribution transformers (EERE-2019-BT-STD-0018) and how they would worsen the distribution transformer supply chain crisis. Discussed need for increased domestic manufacturing of equipment for electric utilities. Discussed H.R. 763, the Supply CHAINS Act, and if the legislation could help address the distribution transformer supply chain issue. Discussed draft legislation, the Protecting Americas Distribution Transformer Supply Chain Act, to prevent DOE from proposing or enacting new energy efficiency standards for distribution transformers for five years. Discussed public power utility access to additional funding for loans for renewable energy created under the Inflation Reduction Act (Pub. Law 117-169), section 22001. Discussed concerns with the DOEs draft guidance to implement section 247 (Maintaining and Enhancing Hydroelectric Incentives) in the Infrastructure Investment and Jobs Act (IIJA)(P.L. 117-58). Discussed, S. 1521, the Community and Hydropower Improvement, and provisions giving tribes mandatory conditioning authority. Discussed the importance of hydropower to rural public power communities. Provided feedback on unintroduced, updated version of legislation from the 117th Congress, the BIG WIRES Act, to give the Federal Energy Regulatory Commission (FERC) the authority to require the expansion of transmission facilities for reliability, among other things (all provisions). Discussed support for permitting reform to help expedite the construction of energy infrastructure (no bill), including changes to the National Environmental Policy Act and changes to the Federal Power Act to expedite the construction of transmission while not saddling public power utilities with transmission costs for which they receive no benefit. Provided feedback on draft legislation, the Clean Electricity Transmission Acceleration Act (all provisions), to direct FERC to determine the existing electricity transfer capacity between regions and to establish minimum levels of transfer capabilities between each region, and to require each transmission planning region to coordinate with its neighbors to plan for the required interregional transmission. Provided feedback on draft permitting reform legislation, the Building American Energy Security Act of 2023 (provisions on transmission). Provided feedback on draft legislation, the CHARGE Act, to promote transmission (all provisions). Discussed concerns with overly broad definitions of the benefits of transmission that would result in utilities and their customers paying for transmission projects from which they derive no benefit. Also discussed the importance of keeping costs affordable for customers. Discussed the importance of keeping rates affordable as new transmission infrastructure is developed. Discussed the importance of joint ownership opportunities for public power utilities as new transmission projects are being built. Discussed the importance of containing costs for customers for building new transmission to accommodate a changing resource mix and to promote reliability and resilience. Discussed concerns with language to set minimum interregional transfer capability between regions being included transmission legislation (no specific bill). Discussed the importance of permitting reform to help build clean energy infrastructure, which will reduce greenhouse gas emissions. Discussed public power programs to promote demand response. Discussed the domestic content requirements in the Inflation Reduction Act (IRA) and Build America requirements in the IIJA, specifically the unique rules that apply to public power and the co-ops. Discussed ensuring the U.S. has adequate natural gas pipeline infrastructure needed for electric reliability. Discussed the public power business model. Discussed how public power utilities are deploying electric vehicle charging infrastructure in their communities.

Client expense: $280,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

Issues relating to the Bonneville Power Administration Issues relating to the Federal Columbia River Power System Issues relating to the implementation of the Water Resources Development Act of 2022 S. 1521, Community and Hydropower Improvement Act

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and policies related to: Pediatric and childrens health research National Institute of Nursing Research H.R. 623/S. 1521, Gabriella Miller Kids First Research Act 2.0 H.R. 6000, Cures 2.0 Act H.R. 7667, Food and Drug Amendments of 2022 S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022

Client expense: Not reported · Firm income: $24,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act and reform of the oversight of Laboratory Developed Tests as outlined in S.2209/HR 4128 the VALID Act and S 3799 the PREVENT Pandemics Act.

Client expense: $122,569 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Legislation and policies related to: Pediatric and childrens health research National Institute of Nursing Research H.R. 623/S. 1521, Gabriella Miller Kids First Research Act 2.0 H.R. 6000, Cures 2.0 Act H.R. 7667, Food and Drug Amendments of 2022 S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022

Client expense: Not reported · Firm income: $24,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act and reform of the oversight of Laboratory Developed Tests as outlined in S.2209/HR 4128 the VALID Act and S 3799 the PREVENT Pandemics Act.

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act and reform of the oversight of Laboratory Developed Tests as outlined in S.2209/HR 4128 the VALID Act and S 3799 the PREVENT Pandemics Act.

Client expense: $78,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act

Client expense: $78,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; CURES 2.0 Discussion Draft

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

S. 281, the Gun Violence Prevention Research Act: To authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention S. 1521, Gabriella Miller Kids First Research Act 2.0: Funding for pediatric research at the National Institutes of Health H.R. 623, Gabriella Miller Kids First Research Act 2.0: Funding for pediatric research at the National Institutes of Health H.R. 825, the Gun Violence Prevention Research Act: To authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention H.R. 1553, Ellies Law: To provide for further comprehensive research at the National Institute of Neurological Disorders and Stroke on unruptured intracranial aneurysms No Bill: To fund the Pediatric Subspecialty Loan Repayment Program No Bill: Funding for National Institutes of Health research on neurologic-related diseases and disorders

Client expense: $35,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 281, the Gun Violence Prevention Research Act: To authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention S. 1521, Gabriella Miller Kids First Research Act 2.0: Funding for pediatric research at the National Institutes of Health H.R. 623, Gabriella Miller Kids First Research Act 2.0: Funding for pediatric research at the National Institutes of Health H.R. 825, the Gun Violence Prevention Research Act: To authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention H.R. 1553, Ellies Law: To provide for further comprehensive research at the National Institute of Neurological Disorders and Stroke on unruptured intracranial aneurysms No Bill: To fund the Pediatric Subspecialty Loan Repayment Program No Bill: Funding for National Institutes of Health research on neurologic-related diseases and disorders

Client expense: $35,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE